Navigating 21st Century Cures Act Home Health Prior Authorization
The 21st Century Cures Act significantly reshapes how home health agencies manage prior authorization, driving mandates for enhanced interoperability and electronic data exchange to streamline patient care. This regulation directly impacts the efficiency of 21st Century Cures Act home health prior authorization processes.
For revenue cycle directors and prior authorization coordinators within home health agencies, understanding the operational implications of the 21st Century Cures Act is critical. This legislation, particularly through its associated rules like CMS-0057-F, introduces new requirements for payers that directly influence how HHAs submit and track prior authorizations for high-volume categories such as episodes of care, specialty home visits, and durable medical equipment (DME).
The Cures Act Mandate for Interoperability in Home Health PA
The 21st Century Cures Act fundamentally aims to enhance interoperability and prevent information blocking across the healthcare ecosystem. For home health agencies, this translates to improved access to patient electronic health information (EHI) from referring providers and a greater expectation for payers to share PA requirements and statuses electronically, fostering a more connected prior authorization environment. This shift is crucial for compiling comprehensive documentation, including OASIS assessments, required for home health episodes.
CMS-0057-F: Direct Impacts on Home Health Prior Authorization
The CMS-0057-F Prior Authorization Final Rule, a direct outcome of the Cures Act, imposes specific mandates on certain payers. These include Medicare Advantage organizations, state Medicaid and CHIP fee-for-service programs, and their managed care plans. For home health agencies, this means these payers are now required to implement FHIR-based APIs for prior authorization, provide reasons for denials, and adhere to significantly shorter turnaround times for PA decisions, directly affecting the submission and tracking of home health episodes and DME.
Key Changes for Home Health Agencies Under the Cures Act
- Shorter Payer Response Times: Mandated 7-day response for standard and 72-hour for urgent PA requests from applicable payers.
- Electronic Access to Payer PA Requirements: Payers must provide API-based access to PA documentation requirements.
- Mandatory Denial Reasons: Payers must provide specific reasons for prior authorization denials.
- Improved Data Exchange for Clinical Documentation: Facilitates easier sharing of EHI, including OASIS data, supporting medical necessity.
- Potential for Streamlined ePA Submissions: While not mandated for providers, the payer-side infrastructure significantly enables electronic prior authorization workflows.
Leveraging FHIR-Based Exchange for HHA Workflows
The Cures Act's emphasis on FHIR-based APIs, particularly through initiatives like Da Vinci PAS, creates a pathway for home health agencies to automate aspects of prior authorization. By integrating with EMRs and payer systems via SMART on FHIR, HHAs can more efficiently retrieve patient clinical data, submit X12 278 transactions or other electronic PA requests for home health episodes and DME, and track PA status without manual portal logins, reducing administrative burden and improving staff productivity.
Strategic Considerations for Home Health PA Automation
While the Cures Act places mandates primarily on payers, home health agencies stand to gain substantial benefits by proactively adopting ePA automation solutions. Integrating a platform that can leverage these new payer APIs, alongside existing electronic submission methods, allows HHAs to optimize workflows for high-volume categories like home health episodes and DME, ensuring compliance with evolving payer requirements and faster patient access to care. Discussing these strategic shifts with your IT and compliance teams is paramount.
Specialty Society Positions and Advocacy
While specific public positions from home health specialty societies on every facet of the Cures Act may vary, the broader sentiment across clinical associations generally supports initiatives that reduce administrative burden, enhance interoperability, and improve patient access to necessary care. The Cures Act's focus on streamlining information exchange and prior authorization aligns with advocacy efforts to ensure timely and appropriate care for home health patients, including those requiring specialty home visits and DME.
Frequently asked questions
How does the 21st Century Cures Act specifically shorten prior authorization turnaround times for home health?
The CMS-0057-F Final Rule, stemming from the Cures Act, mandates that certain payers—specifically Medicare Advantage organizations, Medicaid and CHIP fee-for-service programs, and their managed care plans—must respond to standard prior authorization requests within 7 calendar days and urgent requests within 72 hours. This directly impacts home health agencies serving these populations for home health episodes and DME.
Will the Cures Act require home health agencies to submit prior authorizations electronically?
The Cures Act and CMS-0057-F primarily mandate electronic capabilities for *payers*, requiring them to build FHIR-based APIs for prior authorization. While it doesn't *mandate* providers to use ePA, it creates the infrastructure that significantly incentivizes and facilitates electronic submission and status checking for home health agencies, making ePA adoption a strategic advantage.
What is the role of information blocking in home health prior authorization under the Cures Act?
The Cures Act prohibits information blocking, ensuring that electronic health information (EHI) is readily accessible. For home health prior authorization, this means clinical documentation, including OASIS assessments, physician orders, and therapy notes, should be easily shareable between providers and payers to support medical necessity reviews, reducing delays caused by manual information requests and fostering care coordination.
How can Klivira help home health agencies comply with Cures Act-related PA changes?
Klivira integrates with EMRs and payer portals, leveraging FHIR-based APIs where available to automate the submission of prior authorizations for home health episodes, DME, and specialty visits. Our platform streamlines the collection of necessary clinical data and tracks PA status, helping agencies meet new payer requirements, improve workflow efficiency, and reduce manual administrative tasks inherent in prior authorization.
Does the Cures Act apply to all types of home health prior authorizations?
The specific mandates of CMS-0057-F regarding turnaround times and API usage apply to prior authorizations for medical items and services covered by Medicare Advantage, Medicaid, and CHIP plans. While commercial plans are not directly subject to these specific rules, the broader interoperability goals of the Cures Act encourage similar electronic data exchange across the healthcare ecosystem, influencing all PA types over time for home health agencies.
Related coverage
Ready to stay compliant with this rule?
See how Klivira automates prior authorizations for your team.
Request a demo